BPC reduces the release of inflammatory mediators ( i.e
Product Specifications Compound Name GHK-Cu Alternative Name Copper Tripeptide Compound Class Copper Peptide / Research Peptide Peptide Length 3 Amino Acids Molecular Formula C14H21CuN6O4 Fill Amount 100 mg Form Lyophilized Powder Reconstitution Status Not Reconstituted Container Type Sealed Vial Documentation Batch-Level COA Available Intended Use Laboratory Research Only Handling Qualified Personnel Only Storage Store According to Product Label Research Material Identification GHK-Cu is identified by its copper-bound tripeptide structure, molecular formula, and associated product documentation
Osbert Fernandez MD, FACOG, FAAFP, Medical Director Austin Marie Jacobus RN, MSN, NP-C, VP Clinical
Firstly, NCs decrease and CLCs increase in number during ageing and disc degeneration, which could be explained by the transformation of NCs into CLCs [1]
A preclinical signal may help researchers understand possible mechanisms, but it is not the same as a large human trial showing safety, dosing, effectiveness, and long-term outcomes for a specific condition
It came very fast and easy to do